Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.57 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | ALPL | P05186 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALPG | P10696 | 1/20 | 0.56 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | GALK1 | P51570 | 1/20 | 0.56 |
| ▸ | CASP7 | P55210 | 1/20 | 0.56 |
| ▸ | CASP6 | P55212 | 1/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.56 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.56 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.56 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.54 |
| ▸ | TYR | P14679 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9001318 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL8838912 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL18718056 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL9155988 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL20056672 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL15504372 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL5026360 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL117781 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL9849387 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL18733414 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117412412-B | Graphene far infrared electrothermal film with rapid heat conduction and low energy consumption, and preparation method and application thereof | 江西省极热科技集团有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-117825559-A | Radix tetrastigme decoction pieces produced by Min and detection method thereof, and production place identification method | 宁化县益珍农业科技有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-104478953-A | Method for preparing cigarette fragrance releaser with honey sweet note | CHINA TOBACCO CHUANYU IND CO | 2015-04-01 | — | — | CN | claimed |
| EP-0613478-A1 | IMMUNOSTIMULATING SWAINSONINE ANALOGS | TORONTO RESEARCH CHEMICALS INC. (CA) | 1994-09-07 | — | — | EP | claimed |
| WO-1993009117-A1 | IMMUNOSTIMULATING SWAINSONINE ANALOGS | TORONTO RESEARCH CHEMICALS INC. (CA) | 1993-05-13 | — | — | WO | claimed |
| EP-0394907-A1 | Process for producing etoposides | BEHRINGWERKE Aktiengesellschaft (DE) | 1990-10-31 | — | — | EP | claimed |
| JP-8245675-A | — | — | None | — | — | JP | disclosed |
| CN-117412412-B | Graphene far infrared electrothermal film with rapid heat conduction and low energy consumption, and preparation method and application thereof | 江西省极热科技集团有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-117825559-A | Radix tetrastigme decoction pieces produced by Min and detection method thereof, and production place identification method | 宁化县益珍农业科技有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117427011-A | Preparation method and application of plum blossom supercritical fluid extract | 北京工商大学 | 2024-01-23 | — | — | CN | disclosed |
| CN-117412412-A | Graphene far infrared electrothermal film with rapid heat conduction and low energy consumption, and preparation method and application thereof | 江西省极热科技集团有限公司 | 2024-01-16 | — | — | CN | disclosed |
| EP-3728280-B1 | METHOD FOR IMPROVING THE ORAL BIOAVAILABILITY OF A DRUG | PHARMACYTICS B V (NL) | 2023-06-28 | — | — | EP | disclosed |
| US-11633484-B2 | Method for improving the oral bioavailability of a drug | PHARMACYTICS B.V. (NL) | 2023-04-25 | — | — | US | disclosed |
| US-5066645-A | Antitumor agents | BRISTOL-MYERS COMPANY (US) | 1991-11-19 | — | — | US | disclosed |
| CN-1050719-A | The preparation method of epipodophyllotoxin altrose glycoside derivates | BRISTOL MYERS SQUIBB CO (US) | 1991-04-17 | — | — | CN | disclosed |
| EP-0415453-A2 | Epipodophyllotoxin altroside derivatives | Bristol-Myers Squibb Company (US) | 1991-03-06 | — | — | EP | disclosed |
| EP-0394907-A1 | Process for producing etoposides | BEHRINGWERKE Aktiengesellschaft (DE) | 1990-10-31 | — | — | EP | disclosed |
| EP-0394907-A1 | Process for producing etoposides | BEHRINGWERKE Aktiengesellschaft (DE) | 1990-10-31 | — | — | EP | disclosed |
| US-4686205-A | SELF-FEEDING | RALSTON PURINA COMPANY (US) | 1987-08-11 | — | — | US | disclosed |
| US-4686205-A | SELF-FEEDING | RALSTON PURINA COMPANY (US) | 1987-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11633484-B2 | Method for improving the oral bioavailability of a drug | SI, ABCG2, SLCO1B1 | SLC6A2 191/4885SYNJ2 4037/4885KDM4E 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.